Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2025-12-27 @ 10:58 PM
Study NCT ID:
NCT06145360
Status:
COMPLETED
Last Update Posted:
2024-04-08
First Post:
2023-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Sponsor:
SINA Health Education and Welfare Trust
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-01
Start Date Type:
ACTUAL
Primary Completion Date:
2024-03-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2023-11-17
First Submit QC Date:
None
Study First Post Date:
2023-11-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-05
Last Update Post Date:
2024-04-08
Last Update Post Date Type:
ACTUAL